BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Toray Industries, Inc. (TRYIY) Introduce a New Dimension in Microarray Sensitivity


3/2/2011 12:38:07 PM

London, 2nd March 2011: Toray has today announced the European release of its groundbreaking 3D-Gene™ products, a range of three dimensional DNA chips for use in microarray analysis. The new microarrays utilise several unique features to enhance assay sensitivity, providing the perfect platform for working with low abundance targets such as microRNAs, or troublesome samples such as formalin-fixed paraffin embedded (FFPE) tissue specimens. In a new approach pioneered by Toray, each chip is composed of a black resin that reduces background fluorescence, while probes are attached to three dimensional microcolumns on the surface. In combination, these factors precisely define the spot morphology. The columns are also surrounded by microbeads that are encapsulated on the chip and can be agitated to ensure homogenous sample distribution during the hybridisation process. These properties maximise signal-to-noise ratio and increase accuracy, reproducibility and sensitivity. Importantly, the chips are compatible with current array scanning methods so that no specialised infrastructure is required to utilise the system.

Toray has extensive, global experience in applying its chemistry expertise to the development of innovative solutions across a broad range of applications. The 3D-Gene™ DNA chip technology designed by Toray sets a new benchmark in terms of microarray sensitivity and accuracy. The chips are capable of a high level of precision at concentrations as low as 0.1 attomol, providing an impressive improvement on currently available technologies. This will be especially interesting to those who would like to detect low abundance mRNA and microRNA targets in human, mice and rat samples. The system is also ideal for working with poor quality specimens or those containing a small amount of starting material (e.g., FFPE, serum or plasma), as 3D-Gene™ chips can precisely distinguish background noise from the low numbers of target molecules typically present in these samples.

In addition to the sale of pre-printed arrays, Toray produces customised 3D-Gene™ chips that contain up to 27,000 probes, each manufactured to a stringent set of quality control standards. They also provide a microarray analysis service, allowing researchers to send their samples to be analysed by Toray’s experienced research team using a range of 3D-Gene™ DNA chips.

For more information about 3D-Gene™ chips visit www.3d-gene.com/en/.

The 3D-Gene™ DNA chip is for research use only.

About Toray Industries, Inc:

Founded in 1926, Toray is an international corporation based in Japan with total assets of over $1.5 billion. Toray Group fuses nanotechnology into its operations, using organic synthetic chemistry, polymer chemistry and biotechnology as its core technologies. In addition to the Foundation Businesses of fibres & textiles and plastics & chemicals, Toray also promotes the global development of IT-related products, carbon fibre composite materials, pharmaceuticals and medical products, environment & engineering including water treatment and progress in other pivotal business fields.



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES